Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
Name
Dr. David Moloney
Title
Chief Scientist, Ubotica Technologies
Bio
David has been the Chief Scientist at Ubotica since Jan 2021 and an advisor at the company since inception in 2016.
Formerly he was CTO and co-founder at IntelMovidius and has worked in the semiconductor industry since qualifying with a BEng from DCU in 1985 and PhD from TCD in 2010. He co-founded Movidius as CTO in 2005 which went on to pioneer low-power embedded vision and neural network processing in edge devices before being acquired by Intel in November 2016.
While at Intel David continued to run a small team exploring next generation applications and related hardware as well as engagement with the EU H2020 HiPEAC NoE and also runs Intel’s Edge AI incubator for startups and mature companies who want to build products based on Intel-Movidius Myriad platforms.
While at Movidius David co-authored the H2020 Eyes of Things proposal and drove the project to a very successful conclusion both technically and commercially as one of the spin-outs was Ubotica. He also co-authored the H2020 Bonseyes proposal and participated in the FP7 PHEPPER and EXCESS projects.
He has been granted 41 US patents and has published numerous journal and conference papers (http://bit.do/moloned).
Formerly he was CTO and co-founder at IntelMovidius and has worked in the semiconductor industry since qualifying with a BEng from DCU in 1985 and PhD from TCD in 2010. He co-founded Movidius as CTO in 2005 which went on to pioneer low-power embedded vision and neural network processing in edge devices before being acquired by Intel in November 2016.
While at Intel David continued to run a small team exploring next generation applications and related hardware as well as engagement with the EU H2020 HiPEAC NoE and also runs Intel’s Edge AI incubator for startups and mature companies who want to build products based on Intel-Movidius Myriad platforms.
While at Movidius David co-authored the H2020 Eyes of Things proposal and drove the project to a very successful conclusion both technically and commercially as one of the spin-outs was Ubotica. He also co-authored the H2020 Bonseyes proposal and participated in the FP7 PHEPPER and EXCESS projects.
He has been granted 41 US patents and has published numerous journal and conference papers (http://bit.do/moloned).
